Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Biosimilars – the Brexit of the pharmaceutical industry?

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities...

Blue Latitude Health

- PMLiVE

Victoza cuts cardiovascular risk in landmark study

Novo Nordisk’s diabetes therapy outcomes ‘beyond expectations’

- PMLiVE

Teva suspends migraine patch on burn reports

FDA issues safety alert and instigates investigation into Zecuity

- PMLiVE

miRagen Therapeutics bolsters senior leadership team

Adam Levy and Christopher Mori take on new roles

- PMLiVE

Red Door Unlimited appoints head of social

Antia Buhigas joins the agency’s leadership team

- PMLiVE

Technology: the missing link in true patient engagement?

Approximately 50% of patients do not take their medication as prescribed. This comes at a huge financial cost, and results in suboptimal patient outcomes. There is a wealth of research...

Merck licences MS brain training programme

Strikes deal with HAPPYneuron to bolster its MSdialog platform for Rebif

- PMLiVE

Novo creates online diabetes management resource

Aims to educate UK patients and the public on the signs and impact of hypos

Merck’s accelerator to take start-ups to Silicon Valley

Will expand the reach of its Darmstadt and Nairobi programmes

Sanofi reception

Sanofi boosted by iGlarLixi trials at ADA

Combination of Lantus and Lyxumia showed greater efficacy in controlling type 2 diabetes

UK flag

UK needs ‘Brexit contingency plan’ to protect its science base

Action must be taken to safeguard life sciences in the country, say MPs

- PMLiVE

FDA approves first cholera vaccine in US

PaxVax’s oral vaccine Vaxchora will be launched by September

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links